[16] DPP-4 inhibitors (such as sitagliptin), which enhance incretin activity through a different mechanism Insulin therapy, particularly if oral agents and other injectables are unsuitable Traditional agents like metformin, sulphonylureas, or pioglitazone, depending on individual circumstances NICE guideline NG28 recommends individualised treatment approaches based on HbA1c targets, cardiovascular risk, renal function, and patient preferences
BioMed Research International 2015:648108
Wegovy was authorised for chronic weight management in 2023
They take what you eat and turn it into ATP, the fuel cells run on
Maintenance is often required to sustain results, and discontinuation may lead to a gradual return to the original skin tone
Contraindications generally include: Active or suspected cancer Pregnancy or breastfeeding Severe liver or kidney disease Competitive athletes subject to WADA testing (both peptides are prohibited under the WADA Prohibited List) Eddie will review your history at consultation to make sure peptide therapy is appropriate before anything is prescribed
